ReleaseWire Connect

Curcumin is an ingredient of turmeric which is found in limited amounts in ginger. It is a cancer preventive molecule and is anti inflammatory .It is extracted from turmeric and is widely used in pharmaceuticals, food and cosmetics industry for its anti oxidation and anti inflammatory properties. Curcumin is used in the treatment of tumors, arthritis, gastric ailments and viral infections .Rising consumer awareness towards health benefits of curcumin and growing demand for curcumin-based nutritional supplements due to increasing consumer awareness regarding its anti-cancer properties are the main drivers responsible for the growth of global curcumin market.

The North America oxygen therapy devices market is characterized by the presence of established companies in a large number. Teleflex Inc., Smiths Medical, ResMed, Koninklijke Philips, MAQUET Holding, Invacare Corp., Fisher & Paykel Healthcare, DeVilbiss Healthcare, CareFusion Corp., and Chart Industries are some of the leading vendors of oxygen therapy devices across North America, finds a new study by Transparency Market Research (TMR). These players are constantly striving to innovate and bring in technological advancements to devices in order to gain an edge over the competitors in this market, notes the research study.

The global tourniquet market is intensely competitive and is fairly dynamic, characterized by the presence of a vast number of players, notes Transparency Market Research (TMR). The top players operating in the market are Stryker Corporation, Zimmer Biomet Holdings, Inc., and ulrich GmbH & Co, with the first two companies in North America. Some of the leading vendors of the market are VBM Medizintechnik GmbH, Delfi Medical Innovation, Inc., Hammarplast Medical AB, and Pyng Medical Corporation.

The global medical lifting slings market features a highly consolidated vendor landscape in developed countries, which are domicile to the majority of international players. However, the market remains fragmented in developing countries owing to the presence of a large number of local and small-scale enterprises, observes Transparency Market Research (TMR) in a new study. Market participants across the globe are focusing towards the development of customized products that cater to the specific needs of users, which is likely to intensify the competition in the near future.

The nature of the both the markets for cytology testing and HPV or human papillomavirus testing is oligopolistic in nature, states Transparency Market Research (TMR) in a research report. With the presence of only a handful of leading companies in the market, the competition is not that high as they compete among themselves with different or almost similar strategies. These few players are currently enjoying their reign in the global cytology and HPV testing market. The top three companies namely F.Hoffman-La Roche AG, Hologic, Inc., and Qiagen N.V., at present account for a Herculean share of 86% of the share in the global market HPV testing market and is likely to remain the same over the years ahead.

Rapid and accurate diagnosis is a key factor for effective disease treatment. Increasing incidence of Streptococcus pyogenes infection in Europe, advancement of technology, and rising demand for point-of-care testing act as a high impact drivers of the market. Advancements in techniques such as isothermal nucleic acid amplification tests is likely to propel the market during the forecast period. The molecular diagnostic market for group A streptococcus (GAS) nucleic acid (NA) test in Europe has been segmented based on type of test technique, end-user, and region.

The top five players in the wearable medical devices market accounted for a combined market share of 47.0% in 2014, which leads to some degree of consolidation in an otherwise fragmented market. Some of the leading companies are Polar Electro, Fitbit, Inc., OMRON Corporation, and Medtronic, with OMRON Corporation holding a significant revenue share of almost 11.0% in the same year. The global electronics company increasingly focuses on home healthcare devices, usually portable medical devices such as pedometers and blood pressure monitors to strengthen its shares. Another major player Fitbit, Inc., pioneers in offering wearable technology devices for tracking fitness to gain a competitive edge over others.

Biosensors are the devices used for the detection of analyte and combines physiological detector with biological components. There are certain types of biosensors that include resonant mirror, electrochemical, surface plasmon resonance and light addressable potentiometric.The biosensors market is expected to witness the growth owning to wide range of applications in cardiac monitoring, diabetes monitoring, agriculture, drug recovery, environmental practices and others.

The global lyophilization equipment and services market is primarily driven by a thriving biopharmaceutical industry and rise in contract services, states Transparency Market Research in its latest report. The report is titled "Lyophilization Equipment and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020". The lyophilization market is estimated to grow from a value of US$2.7 Bn in 2013 to US$4.8 Bn by 2020. Developing healthcare sector in emerging economies and introduction of new technologies is projected to boost the market at an 8.50% CAGR from 2014 to 2020.Lyophilization equipment includes tray lyophilizers, freeze drying microscopes, bench-top lyophilizers, and rotary lyophilizers. Accounting for a share of over 45.0% in 2013, tray lyophilizers dominated the market driven by long-term stability of pharmaceutical products and growing use in large-scale production systems. Lyophilization services include aseptic filling, cycle development, and bulk lyophilization. Bulk lyophilization is the largest and the most rapidly developing service segment and is projected to expand at a 6.50% CAGR from 2014 to 2020.

A new research report has been recently published by Transparency Market research and is available for sale on the company website. The research report, titled "Immunoassay Instruments Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020", provides detailed analysis of the global immunoassay instruments market.According to the research study, in 2013, the global market for immunoassay instruments market was worth US$13.5 bn and is anticipated to reach US$23.3 bn by the end of 2020, exhibiting a progressive 8.10% CAGR between 2014 and 2020. The growing prevalence of chronic diseases is the main factor driving the global immunoassay instruments market. In addition, the increasing rate of HIV infections, growing preference for personalized medicine, and technological advancements in immunoassay instruments are propelling the global market. However, the high costs linked with technical advancements is the restraining factor acting upon the global immunoassay instruments market.